Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1106 | 1107 | (Page 1108) | 1109 | 1110 | .... | 1146 | newer

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) According to the new market research report "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape, and geographical markets.

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/healthcare-information-exchange-market-249987292.html

    The health information exchange market is expected to reach USD 1,545.0 Million by 2020 from USD 990.6 Million in 2015, at a CAGR of 9.3%. North America dominated the market in 2015, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

    On the basis of type, the health information exchange market is segmented into directed exchange, query-based exchange, and consumer-mediated exchange. The directed exchange segment accounted for the largest share of the global market in 2015. Directed exchange supports point-to-point transactions and transmits documents to physicians’ EHR; this is contributing to the large share of this segment.

    By setup type, the health information exchange market is segmented into private and public HIE. The private HIE segment accounted for the largest share of the market in 2015 and is expected to grow at the highest CAGR during the forecast period. Factors such as rising number of ACOs and technical capability to connect with other private exchanges are contributing to the large share of this segment.

    Browse and in-depth TOC on " Health Information Exchange Market "

    78 - Tables

    41 - Figures

    201 - Pages

    Allscripts Healthcare Solutions, Inc. (U.S.), RelayHealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Optum, Inc. (U.S.), Covisint Corporation (U.S.), Epic Corporation Inc. (U.S.), and Orion Health (New Zealand) are some of the key players in the global health information exchange market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    Email: mailto:sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/healthcare-information-exchange-market.asp
    Visit Our Website: https://www.marketsandmarkets.com/


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) According to the new market research report “Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

    On the basis of application, the digital therapeutics market is segmented into preventive and treatment/care applications. The preventive applications segment is further categorized into prediabetes and obesity. The treatment/care applications segment is further categorized into cardiovascular diseases, smoking cessation, medication adherence, diabetes, CNS diseases, respiratory diseases, musculoskeletal disorders, and other applications (including wellness; post-operative care; pregnancy and parenting; and personal goals and habit platforms). The preventive applications segment is expected to grow at the highest CAGR during the forecast period. Its high growth can be attributed to government initiatives to increase the focus on preventive healthcare and a rising consensus among policy makers, providers, and patients on the superior effectiveness of preventive measures and behavioral and lifestyle changes as compared to pills or surgical procedures.

    Browse and in-depth TOC on “Digital Therapeutics Market”
    148 - Tables

    36 - Figures

    186 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

    The key strategies followed by most companies in the digital therapeutics market are agreements, collaborations, and partnerships; investments; and new product launches. Among all growth strategies adopted by market players, agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some leading players adopting these strategies include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), and Mango Health Inc. (U.S.).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.asp
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.
    The global Pyrogen Testing market was valued at USD 610.2 Million in 2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.

    The product segments included in the report are kits and reagents, services, and instruments.

    The test segments included in the report are in vitro pyrogen test, LAL (Limulus amebocyte lysate) test, and rabbit test. The LAL test is further subsegmented in to chromogenic tests, turbidimetric tests, and gel clot tests.

    Browse and in-depth TOC on “Bioinformatics Market”
    74 - Tables

    95 - Figures

    173 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html

    A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global pyrogen testing market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates

    Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.) Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 05, 2018 ) Artificial Heart Market are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.

    Request Sample Copy is Available at: http://bit.ly/2OsiIl4

    The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.

    The Major Key Market Players:
    1. SynCardia Systems, LLC
    2. BiVACOR Inc.
    3. CARMAT
    4. Cleveland Heart, Inc.
    5. ABIOMED
    6. ON-X LIFE TECHNOLOGIES INC
    7. Abbott
    8. Cirtec
    9. Thoratec Corporation
    10. MyLVAD

    The "Global Artificial Heart Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial heart market with detailed market segmentation by system and geography. The global artificial heart market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the artificial heart market.

    The global artificial heart market is segmented on the basis of system and geography. Based on system, the market is segmented as, artificial heart, power supply and others. The artificial heart is further classified as, Ventricular Assist Device (VAD) and total artificial heart. The power supply is categorized as, internal battery and external battery.

    The artificial heart market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artificial heart market based on system. It also provides market size and forecast till 2025 for overall artificial heart market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Artificial Heart market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

    North America is expected to contribute to the largest share in the artificial heart market in the coming years, due to technological advancements as well as improved treatment of cardiac conditions in United States and Canada. Asia Pacific is expected to record substantial demand for artificial heart market during the forecast period, due to the rise in geriatric population in various Asian countries.

    The artificial heart market report analyzes factors affecting artificial heart market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The artificial heart market report also includes the profiles of key artificial heart manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the artificial heart market are SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, ON-X LIFE TECHNOLOGIES INC., Abbott, Cirtec, Thoratec Corporation, and MyLVAD, among others.

    Reason to Buy:
    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Artificial Heart Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Artificial Heart Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

    Ask For Discount at: http://bit.ly/2IWrUZO

    About Us:

    The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.



    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 05, 2018 ) Spinal Implants Market Overview

    Spinal implants are used in spondylolisthesis, traumatic fractures, degenerative discopathies and various forms of vertebral instability, including scoliosis during spinal implant surgery. In these surgical procedures, implant systems with preformed shape and function are used as needed. These implants help stabilize and strengthen the spine. They also facilitate fusion and correct deformations. The metals used in spinal implants are stainless steel, titanium or titanium alloys. Implants composed of non-metallic compounds, such as carbon / PEEK, are also present. They are present in many shapes and sizes to serve a wide range of patient age groups. 

    Request for Sample @ https://www.marketdataforecast.com/market-reports/global-spinal-implants-market-3165/request-sample 

    Augmenting geriatric and obese population, technological advancements in spine surgery devices, rising incidence and prevalence of spinal disorders and growing demand for minimally invasive spine surgery are the primary factors driving the growth of Spinal Implants market.

    Cumbersome and stringent processes and regulatory frameworks in developed countries for the approval of product, uncertainty in reimbursement and high cost of treatment procedures are few of the inhibitors market growth. Further, secondary factors like, lack of patient awareness about the newly developed spine treatment procedures coupled with paucity of adequate physician education and government cost containment measures are also contributing to restrain the market growth. 

    Spinal Implants Market Forecast Report (2018-2023)

    Global Spinal Implants market size was around USD 14774 Million in 2018. It is expected to grow at a CAGR of 5.34% to reach USD 19244 Million by 2023 

    Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-spinal-implants-market-3165/ 

    Spinal Implants Market Segmentation

    Global Spinal Implants market can be categorized into three categories: by technology, by product, and by type of surgery. On the basis of technology, Spinal Implants market is classified into Spinal Fusion and Fixation Technologies, Vertebral Compression Fracture Treatment, Motion Preservation/Non-Fusion Technologies and Spinal Decompression. If we go by product, Spinal Implants market is segmented into Thoracic Fusion and Lumbar Fusion Devices. It is further sub-segmented into Posterior Thoracic Fusion and Lumbar Fusion Devices, Interbody Thoracic Fusion and Lumbar Fusion Devices, Cervical Fusion Devices, Spine Biologics, Vcf Treatment Devices, Spinal Decompression, Non-Fusion Devices, and Spine Bone Stimulators.

    Interbody Thoracic Fusion and Lumbar Fusion Devices has been further segmented into By Approach (Anterior Lumbar Interbody Fusion Devices, Posterior Lumbar Interbody Fusion Devices, Transformational Lumbar Interbody Fusion Devices and Axial Lumbar Interbody Fusion Devices), By Material (Non-Bone Interbody Fusion Devices and Bone Interbody Fusion Devices) and Anterior Thoracic Fusion and Lumbar Fusion Devices. Cervical Fusion Devices is further classified into Anterior Cervical Fusion (Anterior Cervical Plates, Cervical Interbody Fusion Devices and Anterior Cervical Screw Systems) and Posterior Cervical Fusion (Posterior Cervical Plates, Posterior Cervical Screws and Posterior Cervical Rods).

    Spine Biologics is further categorized into Dematerialized Bone Matrix, Bone Morphogenetic Proteins, Bone Substitutes, Machined Bones, Cell-Based Matrices and Allografts. Vcf Treatment Devices is further segmented into Balloon Kyphoplasty Devices and Vertebroplasty Devices. Spinal Decompression is further divided into Discectomy, Laminoplasty, Laminectomy, and Laminotomy, Foraminotomy and Foraminectomy, Facetectomy and Corpectomy. Non-Fusion Devices are further classified into Dynamic Stabilization Devices (Interspinous Process Spacers, Pedicle-Based Dynamic Rod Devices and Facet Replacement Products), Artificial Discs (Artificial Cervical Discs and Artificial Lumbar Discs), Annulus Repair Devices and Nuclear Disc Prostheses. Spine Bone Stimulators are further segmented into Non-Invasive Spine Bone Stimulators (Pulsed Electromagnetic Field Devices and Cc and Cmf Devices) and Invasive Spine Bone Stimulators. Last but not the least, on the basis of type of surgery the market is segmented into Open Surgeries, and Minimally Invasive Surgeries.

    By geography, the global Spinal Implants market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presently, North America accounts for the largest market share while Asia Pacific has the highest CAGR. 

    Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-spinal-implants-market-3165/

    Major Players: 

    The major companies dominating this market for its products and services are

    Medtronic, plc (Ireland),
    DePuy Synthesis (U.S.),
    Stryker Corporation (U.S.),
    NuVasive, Inc. (U.S.),
    Zimmer Biomet Holdings, Inc. (U.S.),
    Globus Medical, Inc. (U.S.),
    Alphatec Holdings, Inc. (U.S.),
    Orthofix International N.V. (Netherlands),
    K2M Group Holdings, Inc. (U.S.),
    RTI Surgical, Inc. (U.S.).
     

    Customize Report @ https://www.marketdataforecast.com/market-reports/global-spinal-implants-market-3165/customize-report 

    About Us

    Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

    For more information:

    Abhishek Shukla

    Sales Manager at Market Data Forecast

    Email: abhishek@marketdataforecast.com

    Tel: +1-888-702-9626

    Website: www.marketdataforecast.com


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 05, 2018 ) Trauma Fixation Devices Market Overview

    According to the Centers for Disease Control and Prevention (CDC), trauma is defined as “an injury or wound to a living body caused by the application of external force or violence”. The physical injuries such as burns, fractures, sprains, dislocations, and strains are all classified under trauma. Currently, to treat trauma various treatments are available based on the severity of the injury. Trauma fixation devices are one of the key treatment methods for the aforementioned medical conditions.

    Request for Sample @ https://www.marketdataforecast.com/market-reports/trauma-fixation-devices-market-339/request-sample 

    The upsurge in global geriatric population has augmented the growth of the market, as the aged people possess higher risk for osteoporosis leading to an increased demand for trauma fixation devices. Further, increase in disposable incomes and growing awareness about latest developments in medical field along with the availability of advanced medical facilities, favorable reimbursement policies, a rise in healthcare expenditure, high costs associated with surgeries, competitive pricing, and availability of substitutes have also contributed in the growth of global trauma fixation devices market. However, compatibility issues like infection and allergy associated with the utilization of external and internal trauma fixation devices. Also, the high cost of these devices is inhibiting the adoption or usage of in developing nations (with low disposable income) such as India, China, and Brazil.

    Trauma Fixation Devices Market Forecast Report (2018-2023)

    Global Trauma Fixation Devices Market is predicted to reach USD 7.99 Billion by 2023 from USD 5.9 Billion in 2018, growing at a CAGR of 6.24%.

    Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/trauma-fixation-devices-market-339/ 

    Trauma Fixation Devices Market Segmentation

    The global trauma fixation devices market is segmented on the basis of type into internal and external fixation devices. Internal fixation devices are employed in fixing fractured bones indefinite shape by implanting various devices. Further, the internal trauma fixation devices are classified into Screws, Plates, Rods, Wires and Intramedullary nails. Whereas the external trauma fixation devices are segmented on the basis of technology into Unilateral, Circular and Hybrid Fixation. The internal trauma fixation devices segment holds the largest share, representing about 85% of the global trauma fixation devices market. Further, the demand for better services in trauma surgeries has led manufacturers to develop products that are less invasive and more anatomical, such as low-profile plating system for extremity fixation procedures. 

    Furthermore, on the basis of geography, the global market for trauma fixation devices is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. North America represents the largest share of the global trauma devices market, owing to supportive government policies facilitating the purchase of these devices. The rise in geriatric population and personal disposable income of people in Asian countries such as China and India are contributing to the market growth in these emerging nations. Latin American countries such as Brazil and Mexico are anticipated to register greater market growth for trauma devices owing to improving access to healthcare, higher accident cases, and favorable demographics. 

    Buy now @ https://www.marketdataforecast.com/cart/buy-now/trauma-fixation-devices-market-339/ 

    Major Players: 

    The major companies dominating this market for its products and services are

    DePuy Synthesis,
    Smith & Nephew,
    Stryker Corporation,
    Zimmer,
    Biomet
     Integra Life sciences Corporation,
    Arthrex, Medtronic, Inc.,
    Conmed
    Bioretec, Inc. 

    Customize Report @ https://www.marketdataforecast.com/market-reports/trauma-fixation-devices-market-339/customize-report 

    About Us

    Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. 

    For more information:

    Abhishek Shukla

    Sales Manager at Market Data Forecast

    Email: abhishek@marketdataforecast.com

    Tel: +1-888-702-9626

    Website: www.marketdataforecast.com


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 05, 2018 ) Global Dialysis Equipment Market Overview

    Dialysis machines are used as artificial kidneys to filter waste products and excess fluids from blood. These machines are used in case of kidney failure or in any case where kidneys couldn’t do their job properly. Dialysis machines can be temporary or permanent depending on whether the kidney transplant is possible or not. 

    Request for Sample @ https://www.marketdataforecast.com/market-reports/global-dialysis-equipment-market-1941/request-sample 

    Increasing aging Population, rising incidence of kidney diseases, increasing number of diabetes and hypertension patients, and technological advancements in healthcare industry are some of the major drivers driving the Dialysis Equipment Market. However, factors like low awareness about kidney disease treatment and decreasing medical reimbursements for dialysis treatment are restricting the growth of the market. 

    Global Dialysis Equipment Market Forecast Report (2018-2023)

    Global Dialysis Equipment Market was worth USD 17.01 billion in 2018 and is expected to reach USD 23.31 billion by 2023 with a CAGR of 6.5 %. 

    Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-dialysis-equipment-market-1941/

    Global Dialysis Equipment Market Segmentation

    Dialysis Equipment market is segmented based on Type and End User. Based on Type, market is segmented into Hemodialysis Equipment, Peritoneal Dialysis Equipment, Continuous Renal Replacement Therapy Systems, and Dialysis Accessories. Based on Hemodialysis Equipment, market is further segmented into Hemodialysis Machines, Dialyzers, and Blood Access Device Dialysate. Based on Peritoneal Dialysis Equipment, market is further segmented into Continuous Cycling Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Intermittent Peritoneal Dialysis. Based on End User, market is segmented into In-center Dialysis, Home care Dialysis. Hemodialysis segment dominates the market with over 88 % of the market share with dialyzers as its major segment during the forecast period. This is because of this method’s lower risk of infections. Peritoneal Dialysis Equipment is expected to grow at the fastest CAGR owing to the self-administrable and needleless treatment. In End User segment, Home care segment is expected to witness faster growth during the forecast period. 

    Geographically, market is segmented into Europe, Asia-Pacific, North America, Latin America and Middle East and Africa. North America is expected to be the dominant market owing to the presence of advanced technology and availability of medical reimbursements. Asia-Pacific is expected to be the fastest growing market owing to the rising ESRD Patients, rising healthcare expenditure and increasing awareness about dialysis centers among people. 

    Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-dialysis-equipment-market-1941/
     

    Major Players: 

    The major companies dominating this market for its products and services are

    Fresenius Medical Care AG & Co.,
    Gambro AB,
    Baxter International Inc.,
    Nipro Inc.,
    ALLMED Medical GmbH,
    Asahi Kasei Corporation.
     

    Customize Report @ https://www.marketdataforecast.com/market-reports/global-dialysis-equipment-market-1941/customize-report 

    About Us

    Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. 

    For more information:

    Abhishek Shukla

    Sales Manager at Market Data Forecast

    Email: abhishek@marketdataforecast.com

    Tel: +1-888-702-9626

    Website: www.marketdataforecast.com


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 05, 2018 ) Neurological Monitoring Devices Market Overview

    Neurological Monitoring Devices are being incorporated extensively in the hospitals and clinics for assessing the activity of sedatives and anesthesia. Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of Electroencephalography EEG devices. Standardization in the process for brain monitoring and growing number of clinical trials for neuro-cognitive diseases is anticipated to offer good opportunity for the market.

    Request for Sample @ https://www.marketdataforecast.com/market-reports/global-neurological-monitoring-devices-market-2232/request-sample

    Factors such as the rising incidence and prevalence of neurological disorders, increasing awareness about neurodegenerative diseases, technological developments in devices and increasing incidence of traumatic brain injuries are driving market growth. On the other hand lack of skilled professionals, high cost of complex devices, poor reimbursement policies and concern regarding the accuracy of diagnostic devices are restricting the market growth.

    Neurological Monitoring Devices Market Forecast Report (2018-2023)

    Global Neurological Monitoring Devices Market was worth USD 8.49 billion in 2018 and estimated to be growing at a CAGR of 7.1%, to reach USD 11.96 billion by 2023.

    Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-neurological-monitoring-devices-market-2232/

     

    Neurological Monitoring Devices Market Segmentation

    The global neurological monitoring devices market is segmented on the basis of type into Monitors of Intracranial Pressure & Blood Flow Dynamics and Monitors of Brain Electrical Activity. Monitors of Intracranial Pressure & Blood Flow Dynamics segment is further divided into Intracranial Pressure Monitor, Jugular Venous Oximetry, Transcranial Doppler (TCD) Ultrasonography, Near-Infrared Spectroscopy and Brain Tissue Oxygen Tension Monitor. Monitors of Brain Electrical Activity segment is sub-segmented into Electroencephalography and Evoked Potentials. Based on procedure the market is segregated into Non-Invasive and Invasive. On the basis of therapeutic application, market is bifurcated into Brain Injuries, Stroke, Dementia, Headache Disorders, Sleep Disorders, Epilepsy, Parkinson’s disease and Huntington’s disease. By End User, the market segmentation is among Hospitals, Neurological Centers and Institutions, Clinics & Ambulatory Surgical Centers, Diagnostic Centers and Ambulances.

    Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America holds the largest share of the neurological monitoring devices market due to the advancement of technology and improved healthcare facilities. This is closely followed by Europe but Asia-Pacific has the fastest growing market because of huge investments being made in healthcare research and the developing economy.

    Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-neurological-monitoring-devices-market-2232/

    Major Players: 

    The major companies dominating this market for its products and services are

    CAS Medical Systems Inc.,
    Compumedics Ltd.,
    Natus Medical Inc.,
    Philips Healthcare,
    GE Healthcare,
    AMD Global Telemedicine,
    Intel Corporation,
    Johnson & Johnson,
    In Touch Health,
    InTechnology,
    MEG International Services Ltd.,
    Rimed Inc.,
    Siemens Healthcare,
    Medtronic Inc.,
    Electrical Geodesics Incorporated,
    Nihon Kohden Corporation
    Advanced Brain Monitoring.
    Customize Report @ https://www.marketdataforecast.com/market-reports/global-neurological-monitoring-devices-market-2232/customize-report

    About Us

    Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

    For more information:

    Abhishek Shukla

    Sales Manager at Market Data Forecast

    Email: abhishek@marketdataforecast.com

    Tel: +1-888-702-9626

    Website: www.marketdataforecast.com


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) In order to study the various trends and patterns prevailing in the concerned market, Fact.MR has included a new report titled “Chromatography Syringes Market: Technological Improvements Steering Growth during 2017-2022” to its wide online database including upcoming trends and growth factors. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. The report studies the Global Chromatography Syringes Market Demands, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions. The intelligent report also anticipates that the market would grow at a constructive CAGR until 2022.

    Request 100 Page Sample Report from Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=153

    Chromatography syringes function primarily as a liquid transfer device, or, as a pipette for loading sample loops. These syringes are leak-proof and gas-tight. Chromatography syringes do not have an active part in injection that occurs after displacement of the sample from the syringe. Standard needles utilized for chromatography are usually point style 3 (blunt point), or, 2 (sharp point).

    Chromatographic syringes are designed to offer the highest performance in applications including liquid, and gas chromatography, and handling corrosive gases, liquids, sterile solutions, and radioactive materials. A solid domed tip rendered in chromatography syringes help to minimize septum damage. In manual gas chromatography injections, the style two beveled tip injection is preferred by chemists. Demand for chromatography syringes has witnessed a surge on the back of changing regulatory framework, coupled with the rise in consumer concerns related to food safety. Chromatography tests have become imperative for drug approvals. Various technological advancements in chromatography syringes have been witnessed in order to fulfil the requirements of biotechnology, biopharmaceutical, food & beverage, chemical, and semiconductor industries. Demand for chromatography syringes are also being driven by factors such as increasing necessity of research such as purification of monoclonal antibodies, green chromatography, and rapid utilization of chromatography in proteomics. The aforementioned factors are expected to augment growth of the global chromatography syringes market.

    However, chromatography syringes are difficult to use in conventional methods. In addition, these syringes possess less sample capacity, which makes chromatography a time consuming process, as careful attention is needed when chromatography syringes are used. These factors will curb the market growth over the forecast period. Leading players in the global chromatography syringes market are focusing on the development of more advanced system for chromatography syringes. The global market for chromatography syringes is estimated to register an impressive CAGR throughout the forecast period (2017-2022). The global chromatography syringes market is estimated to reach approximately US$ 85 Mn in revenues by 2022-end.

    To View Full Global Market Research Report Click Here - https://www.factmr.com/report/153/chromatography-syringes-market

    By product type, autosampler syringes for chromatography will remain preferred in the market, with revenues expected to account for over half share of the market during 2017 to 2022. Sales of manual syringes for chromatography will continue to register a comparatively lower CAGR than autosampler syringes through 2022.

    Although chromatography syringes are projected to find the largest application in gas chromatography, sales of chromatography syringes for application in high pressure liquid chromatography (HPLC) are estimated to register the highest CAGR through 2022. Demand for chromatography syringes in thin layer chromatography will remain comparatively lower than that in gas chromatography, and HPLC applications over the forecast period.

    Complete Loop Filling - The Most Lucrative Technology for Chromatography Syringes

    Complete loop filling is projected to be the most lucrative technology for chromatography syringes, with sales expected to exceed revenues worth US$ 30 Mn by 2022-end. However sales of partial loop filling chromatography syringes are expected to reflect the fastest expansion in the market through 2022.

    Research institutes will continue to be the largest end-users of chromatography syringes during 2017 to 2022, while sales of chromatography syringes in pharmaceutical industry are estimated to exhibit the highest CAGR through 2022.

    Competition Tracking

    Key market players profiled in Fact.MR’s report include Hamilton Company, Agilent Technologies, Thermo Fisher Scientific, Inc., Valiant Co., Ltd., PerkinElmer, Inc., Trajan Scientific & Medical Pty Ltd., and Shimadzu Corporation.

    Buy Useful Figures about Global Market Report from Here - https://www.factmr.com/checkout/153/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) This global market research report titled “Global Cutting Balloon Catheter Market Insights, Movements & Future Development Status Recorded during 2017-2022” focuses on the Cutting Balloon Catheter Market, published to the vast repository managed by Fact.MR. The analysis focuses on the prime geographical regions based on their market size, revenue and attractiveness factors. Furthermore, the research discusses various segments from the cutting balloon catheter market to examine future lucrativeness and spot growth prospects through 2017-2022.  Readers can even access information such as key developments, technologies, innovations, etc., concerned to the Cutting Balloon Catheter Market.

    Request for Free Sample Report of Described Market from Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=145

    Adoption of cutting balloon catheter is expected to remain sluggish during the forecast period. This is primarily owing the arrival of better alternatives for undertaking minimally invasive endovascular procedures. Due to tremendous advancement in medical technology, a slew of advanced catheters have been developed to treat arterial atherosclerosis. In addition, rising prevalence of cardiovascular ailments is prompting the need for more efficient balloon catheters. Medical device manufacturers are focusing on developing multipurpose balloon catheters owing to a higher consumer preference for such devices. Factors as such are making a negative impact on the global sales of cutting balloon catheters.

    However, cutting balloon catheter will stay relevant to most healthcare settings as surgeons and physicians will continue to use them in various medical cardiovascular surgeries. As per the latest report published by Fact.MR, the global cutting balloon market will expand at a miniscule CAGR of 2.4% between 2017 and 2022.

    A cutting balloon catheter is a medical device used in angioplasty procedures, and was invented by Barath et al. It allows percutaneous coronary interventions in arteries or veins. The device incorporates a distinctive tip with microsurgical blades, which can be activated by inflating the balloon.  Boston Scientific's Flextome is the one of the most commonly used cutting balloon catheter device.

    North America Spearheading the Global Cutting Balloon Catheter Market

    The cutting balloon catheter market in North America is expected to remain attractive in 2017 and beyond. This is owing to existence of an advanced healthcare infrastructure coupled with the rising healthcare spending in countries such as the U.S. and Canada. Meanwhile, Europe is estimated to account for more than 30% revenue share of the market by 2017-end. The market in Asia-Pacific excluding Japan (APEJ) is projected to witness the higher CAGR during the forecast period.

    You can Access Complete Factors of Market Report In-Depth Here - https://www.factmr.com/report/145/cutting-balloon-catheter-market

    On the basis of indication, the coronary artery disease cutting balloon catheter segment is projected to hold its dominant position over the assessment period. Currently, the segment accounts for close to 73% share of the market in terms of revenue. In addition, the segment is expected to reach a market valuation of over US$ 134 Mn towards the end of 2022.

    Based on end user, the hospitals segment will retain its dominance over 2022. The segment is projected to surpass a valuation of US$ 121 Mn by the end of forecast period. The segment currently accounts for nearly 67% revenue share of the global market and is expected to create absolute $ opportunity of US$ 12 Mn from 2017 to 2022.

    Competition Tracking

    Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic Plc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Cordis Corporation, Cook Medical Inc., MicroPort Scientific Corporation, Cardionovum GmbH, Meril Life Sciences Pvt Ltd, and Hexacath are the leading market players mentioned in the Fact.MR’s report. Majority of these player are concentrating on further production innovation.

    Grab Customized Market Report from Here - https://www.factmr.com/checkout/145/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) Data mining, which is intensively and extensively being utilized by several organizations, is gaining high popularity in the life sciences sector, albeit the degree of essentiality is moderate. Data mining applications have significantly benefitted industries, for example – insurers can detect abuse and fraud, lifesciences companies can make better decisions apropos to customer relationship management, physicians can identify best practices and effective treatment options, and patients are enabled to receive affordable and improved healthcare services. With huge amount of complex data generated by the transactions related to life sciences companies, processing and analyzing this data becomes voluminous by traditional methods. With the help of data mining’s methodology and technology, the process of transforming the complex data into useful information is facilitated.

    Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=459

    As the lifesciences industry continues to evolve, optimizing effectiveness of capital investment decisions is gaining paramount importance among life sciences industries. Decisions concerning facility function and location are indispensable, as proximity to services plays an imperative role in growth of the industry. Lifescience data visualization is therefore gaining huge momentum with its provision of application-specific data along with infographics. As lifescience data visualization facilitates understanding of the complex data’s graphical representation, companies are leveraging the technology for making improvements in facilities. One of the latest trend observed in the market is increasing importance of sharing life science data visualization in a bid to enable discerning of results in a format that is easy to understand.

    The global healthcare data mining & visualization market has been slated to reflect a spectacular rise between the forecast period 2017 and 2026. The market has been estimated to surpass US$ 6,000 Mn in revenues by 2026-end.

    Companies Leveraging Lifesciences Data Visualization to Make Improvements in their Facilities

    With the business of lifesciences witnessing continuous evolution, optimizing effectiveness of decisions related to capital investment is gaining paramount importance within the industries. The decisions apropos to facility function & location are indispensable, mainly because proximity to services plays pivotal role. Lifescience data visualization has therefore been gaining huge momentum along with its provision of the application-specific data and infographics. Lifescience data visualization facilitates better understanding of complex data’s graphical representation, which has led companies to capitalize on the technology with an aim to make improvements in their facilities. A popular trend witnessed in the market is increasing importance of sharing lifescience data visualization in a bid to enable discerning of results in a format that is easy to understand.

    Data mining is intensively & extensively being utilized by several lifesciences organizations, and is gaining immense popularity in the industry, although the degree of essentiality has been moderate. The data mining applications significantly benefit the lifesciences companies, for example, these organizations can make correct decisions associated with customer relationship management, thereby enabling physicians in identifying best practices as well as effective treatment options. Patients are provided with affordable & improved healthcare services. Huge amount of highly complex data created by transactions apropos to the lifesciences industry entails challenges such as processing and analyzing the voluminous data by using traditional methods. However, with the help of methodology and technology of data mining, the process of transforming this complex data into a useful intelligence is facilitated.

    Browse Full Report with TOC @  https://www.factmr.com/report/459/lifesciences-data-mining-visualization-market

    North America to Account for Largest Revenues in the Market

    Revenues from the market for lifesciences data mining and visualization in North America will remain significantly larger than those obtained from the market in all the other regional segments combined. Apart from North America, Europe will also prevail as a lucrative market for lifesciences data mining and visualization market.

    On the basis of customer segment, pharmaceuticals will witness the fastest expansion in the market during 2017 to 2026. In addition, revenues from academia and diagnostics & screening will increase at an approximately equal CAGR through 2026. Sales & marketing will endure as the most lucrative among solution type segments, trailed by operations and supply chain.

    Table of content:

    Global Economic Outlook
    Global lifesciences data mining and visualization market - Executive Summary
    2.1. Opportunity Analysis
    2.2. Megatrends
    Global Lifesciences Data Mining and Visualization Market Overview
    3.1. Introduction
         3.1.1. Global Lifesciences Data Mining and Visualization Market Taxonomy
         3.1.2. Global Lifesciences Data Mining and Visualization Market Definition
    3.2. Global Lifesciences Data Mining and Visualization Market Size (US$ Mn) and Forecast, 2012-2026
           3.2.1. Global Lifesciences Data Mining and Visualization Market Y-o-Y Growth
    3.3. Global Lifesciences Data Mining and Visualization Market Dynamics
    3.4. Vendor Survey
    3.5. Wise Investment Perception - End Use Industry Survey
    3.6. Data Visualization Category Assessment
    3.7. Solution Type Assessment
    3.8. Porter's Analysis
    3.9. PESTLE Analysis
    3.10. Product Lifecycle
    3.11. Competition Matrix
    3.12. Investment Feasibility Scenario
    3.13. Key Participants Market Presence (Intensity Map) By Region
    Continued………...

    Buy this Report @ https://www.factmr.com/checkout/459/S

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) In order to study the numerous upcoming trends and patterns prevailing in the Global Deodorants Market, Fact.MR has included the latest Forecast report on Drug Eluting Balloon Catheter Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Global Drug Eluting Balloon Catheter Market Future Movements by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

    Request for Sample of this Global Market Research Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=146

    Drug eluting balloon catheter is an advanced medical device which has shown remarkable efficiency in carrying out various peripheral artery and cardiovascular procedures. A large number of companies are now shifting towards manufacturing of drug eluting balloon catheters as they are proving to be more efficient as compared to stenting or balloon angioplasty. In addition, drug eluting balloon catheter can also help in treating patients who do not benefit from percutaneous coronary intervention (PCI). Factors as such are expected to favour the global drug eluting balloon catheter market in the near future. Increasing number of patients with cardiovascular ailments and surging rate of cardiology intervention procedures is driving the demand for drug eluting balloon catheter.

    Manufacturers are also trying to develop low-cost devices, which will further boost its adoption over the next couple of years. As per the latest report publish by Fact.MR, the global drug eluting balloon catheter market is poised to grow reflect a staggering CAGR of 18.3% during the forecast period 2018 and 2022. At the same time, improved reimbursement support, increasing healthcare expenditure and growing geriatric population are some of the other additional factors likely to influence the growth of the market.

    Drug-eluting balloon (DEB), also known as drug-coated balloon (DCB) is one of the newest medical devices under the catheter segment.  Drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.

    Request Global Market Report with TOC Here - https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

    By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

    By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.

    Competition Tracking

    Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.

    Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.

    To Buy Global Market Research Report, Go with this Link - https://www.factmr.com/checkout/146/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) Dual chamber prefilled syringes are being widely utilized for storing biological substances or active pharmaceutical components that cannot be stable for extended duration. These syringes enable avoiding drug loss by maintaining sterility of drugs prior to injection. Advancement in technology has resulted into improved arrangement of liquid components in syringes and injectors, attracting more patients toward opting for these safe and efficient syringes.

    Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=486

    Lyophilized drugs have witnessed a robust penetration across the globe in the recent past. These drugs account for a major share of the all reconstitution-requiring injectable/infusible. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.

    A CAGR of 8.7% has been projected for the Global Dual Chamber Prefilled Syringes Market during the forecast period, 2017 to 2026, according to a new study of Fact.MR. Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.

    North America will continue to be the most remunerative market for dual chamber prefilled syringes. Dominance of North America in the market can be highly attributed to growing prevalence of chronic diseases in the region coupled with high penetration of biologics and biosimilars. Geographical expansion of North America-based market players, high demand for self-injection devices and growing geriatric population are some other factors driving growth of the market in North America.

    Request Full Report with TOC: https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market

    Conventional prefilled syringes are expected to remain sought-after among products in the global Dual Chamber Prefilled Syringes Market. This can be attributed to factors such as relatively lower cost along with robust adoption of self-administered drugs. Safety prefilled syringes are expected to record a comparatively faster sales expansion through 2026, mainly driven by growing focus of manufacturers in introducing technologically advanced and safe & efficient drug delivering prefilled syringes for minimizing risk to patients.

    Glass to Remain Preferred Product Material for Dual Chamber Prefilled Syringes

    Glass will remain preferred product material for dual chamber prefilled syringes, mainly because of its non-reactive nature, and properties such as chemical and heat resistance. However sales of glass prefilled syringes will witness a comparatively slower expansion than plastic prefilled syringes through 2026.

    Although hospital pharmacies are estimated to account for the largest market share during the forecast period, sales of dual chamber prefilled syringes in online pharmacies are poised to record the highest CAGR through 2026.

    Competition Tracking

    With trend toward surging adoption of self-injection syringes, and development of technologically advanced dual chamber prefilled syringes, leading players in the market are concentrating on expansion of their product portfolio and the market reach. In this highly competitive and rapidly evolving market, players are emphasizing on the essentiality of up-to-date information for monitoring their performance and making critical decisions regarding profitability & growth.

    Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.

    Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=486

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    Sharik
    353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Injection Robot Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/MnE/QBI-LPI-MnE-120039

    The key players profiled in this report include: Engel, Kraussmaffei, Yushin, Wittmann, Epson, Star Seiki, Sepro, Güdel, Harmo, Kuka, Wemo, Alfa-Robot, Ranger Automation Systems
    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Injection Robot Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Injection Robot Market”.
    “Global Injection Robot Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/MnE/QBI-LPI-MnE-120039

    The “Global Injection Robot Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/MnE/QBI-LPI-MnE-120039

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Injection Robot Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/MnE/QBI-LPI-MnE-120039/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) An up-to-date research report has been disclosed by Fact.MR highlighting the titled “Rising Demand Drives Normal Balloon Catheter Market Growth during the Forecast Period: 2017-2022” which delivers an outlook of current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR during 2017-2022. The report studies the Rising Demand of Normal Balloon Catheter Market Worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions.

    To Get Sample Copy of Current Report, Visit Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=147

    Normal balloon catheter, an innovative medical device, comprises a catheter and a guidewire that is inserted into femoral artery in the legs, or, sometimes into radial artery in arms for treating constricted blood vessels. Generally normal balloon catheter is utilized for preventing blood vessel constriction, which is caused by atherosclerosis, i.e. deposition of the lipid substances in blood vessels.

    The surge in interventional cardiology has been facilitating the utilization of normal balloon catheters. Moreover, there is a rise in prevalence of patients affected with the end stage renal disease. The number of patients seeking for renal replacement therapy has also increased. Leading manufacturers of normal balloon catheters are developing efficient and cost-effective solutions. These incidences might influence growth of the global normal balloon catheter market in the upcoming years. In contrast, costs of angioplasty procedures are very high, coupled with the risks such as artery collapse and infection related to balloon catheterization, which in turn will impede growth of the market.

    The number of cardiovascular diseases has been witnessing a rise, along with growing cases of cardiology intervention procedures worldwide. Several governments are providing reimbursement support for people suffering from vascular diseases. There has also been a hike in healthcare expenditure. These factors might favor demand for normal balloon catheters. In addition, various other factors such as growing geriatric population, rising investments in research & development activities concerning normal balloon catheters are expected to pave potential growth opportunities for manufacturers of normal balloon catheters. The global market for balloon catheter is likely to exhibit a moderate growth during 2017 to 2022. Revenues from the global market for normal balloon catheter will reach nearly US$ 2,000 Mn by 2022-end.

    Europe to Account for the Largest Revenue Share of the Market during 2017 to 2022

    In terms of revenues, Europe will account for the largest share of the market during the forecast period. Europe will continue to be the most lucrative market for normal balloon catheter. Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will register the highest CAGR through 2022. In contrast, sales of normal balloon catheter in North America will exhibit the lowest CAGR in the market through 2022.

    Read Complete Factors about Global Market Report from Here - https://www.factmr.com/report/147/normal-balloon-catheter-market

    By indication, coronary artery disease will remain dominant in the global market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end. Approximately three-fourth revenue share of the market will be accounted by sales of normal balloon catheter for coronary artery disease during 2017 to 2022.

    Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

    Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

    Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half revenue share of the market will be accounted by nylon, based on raw material. However, sales of polyurethane for production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

    Competition Tracking

    Key players profiled in Fact.MR’s report include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.

    Buy online this Report from Here - https://www.factmr.com/checkout/147/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Daptomycin Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-119010

    The key players profiled in this report include: Carl Zeiss, Essilor, Huvitz Co Ltd, Luneau Technology Group, Nidek Co., Ltd., Ningbo FLO Optical Co., Ltd, Reichert, Rexxam Co., Ltd., Righton, Shanghai JingLian Group
    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Daptomycin Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Daptomycin Market”.
    “Global Daptomycin Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-119010

    The “Global Daptomycin Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-119010

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Daptomycin Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-119010/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Infliximab and biosimilar Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-119011

    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Infliximab and biosimilar Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Infliximab and biosimilar Market”.
    “Global Infliximab and biosimilar Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-119011

    The “Global Infliximab and biosimilar Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-119011

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Infliximab and biosimilar Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-119011/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) In order to study the numerous upcoming trends and patterns prevailing in the Global Deodorants Market, Fact.MR has included the latest Forecast report on Scoring Balloon Catheter Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Scoring Balloon Catheter Market Future Trends by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

    Request 100 Page Sample Report from Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=148

    The global scoring balloon catheter market is predicted to reflect a sluggish growth attributed to increasing risk of infection and artery collapse. Scoring balloon catheter devices witness a steady demand among the healthcare professionals globally. Increasing preference for scoring balloon catheters over conventional catheters attributed to limited features in the healthcare industry will fuel growth of the global market. Hospitals will witness steady growth in terms of consumption in the global market during the predicted period. Polyurethane will register the highest revenue growth in the global scoring balloon catheter market by the end of 2017. Coronary artery disease in terms of disease indication is expected to generate significant revenue in the global market in 2017.

    Scoring Balloon Catheters are used for dialysis of renal and peripheral vascular diseases. These devices also witness a considerable demand among the healthcare professionals due to growing need for coronary artery diseases. Scoring balloon catheters witness more preference as compared to the conventional catheters attributed to uncontrolled dissection including insufficient luminal expansion.

    According to Fact.MR's forecast, the global scoring balloon catheter market is expected to register a slow CAGR, and will represent a value of more than US$ 200 Mn by the end of 2022.

    Consumption in Healthcare Industry

    Equipped with enhanced technology, scoring balloon catheters have brought respite to the patients of coronary artery disease. Despite increasing risks of artery collapse during the catheterization process, the scoring balloon catheters is expected to witness considerable demand in the healthcare sector. Conventional balloons are bound to limitations including insufficient luminal expansion and bailout stenting due to uncontrolled dissection. Scoring technology enables superior luminal expansion through re-expansion of original stent and effective mechanical dilatation of the neointimal tissue. Attributed to benefits of treating ISR without slippage, the scoring balloon catheters are more preferred over the conventional devices in the healthcare industry.

    To View Full Global Market Research Report Click Here - https://www.factmr.com/report/148/scoring-balloon-catheter-market

    Moreover, insufficient luminal expansion during treatment of fibrocalcific lesion through conventional devices and resistance to the dilatation has led manufacturers to adopt scoring technology for production of balloon catheters. Conventional balloons are bound to lower patency rate and repetitive revascularization. Due to such factors, the scoring balloon catheters are more preferred during the treatment process as compared to the conventional devices.

    However, growing risk artery collapse attributed to catheterization process is predicted to hinder growth of the global scoring balloon catheter by the end of 2022. Moreover, increasing risk of infections due to catheterization treatment is expected to pose challenges for the global market of scoring balloon catheters. Such factors are likely to impact growth of the global scoring balloon catheter market negatively during the predicted period.

    Hospitals to Remain a Leading Segment

    Coronary artery diseases is expected to witness the highest growth in terms of revenue in the global market. This segment is predicted to register the highest CAGR in APEJ. Coronary artery diseases will represent a value of nearly US$ 40 Mn in 2017. Peripheral vascular disease as compared to other disease indication is expected to represent the second highest revenue growth in the global scoring balloon market.

    Hospitals is expected to represent the highest revenue growth in the global scoring balloon market by the end of 2022. Europe is predicted to represent the largest market share globally during the predicted period. Cardiac catheterization laboratories is expected to represent the second highest revenue growth in the global scoring balloon catheter market by 2022 – end. This segment is expected to register the highest CAGR growth in the global scoring balloon catheter market through 2022.

    Buy Useful Figures about Global Market Report from Here - https://www.factmr.com/checkout/148/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Lovastatin Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-119006

    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Lovastatin Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Lovastatin Market”.
    “Global Lovastatin Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-119006

    The “Global Lovastatin Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-119006

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Lovastatin Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-119006/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) An up-to-date research report has been disclosed by Fact.MR highlighting the titled “Stent Graft Balloon Catheter Market Projected to Experience Major Revenue Boost during the Period between 2017-2022” which delivers an outlook of current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR of 5.1% during 2017-2022. The Report Studies the Stent Graft Balloon Catheter Market Worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions.

    Request Here for Free Sample of Global Market Research Report Now - https://www.factmr.com/connectus/sample?flag=S&rep_id=149

    Stent graft balloon catheters are soft catheters equipped with inflatable balloons, and are utilized during a catheterization process, in order to enlarge the narrow opening in coronary artery. Stent graft balloon catheter are generally used to expand vascular prosthesis, or at times of temporary occlusion of huge vessels, thereby utilized in several endovascular treatment of thoracic, aortic, and abdominal diseases.

    Usually, stent graft balloon catheters are adopted in balloon angioplasty and bypass graft surgery. These stents prevent risks related to re-narrowing that occurs in several patients undergoing angioplasty, as well as risks associated with abrupt artery closure. On the back of these benefits, demand for stent graft balloon catheters is on a rise. The market for stent graft balloon catheter has witnessed a gradual evolution from simple stents to the modified balloon stent catheters. Over the recent past, number of hospital admissions has witnessed a surge, owing to rising incidences of atherosclerosis, and growing prevalence of coronary artery disease (CAD) around the world. A number of technological developments have been observed in balloon catheters, coupled with the rise in healthcare expenditure.

    However, angioplasty procedures are unaffordable, particularly for population thriving in underdeveloped and developing economies, which in turn might restrain demand for stent graft balloon catheters. Introduction of drug eluting balloons has highly favored growth of the market. Moreover, rising inclination toward adoption of balloons with drug delivery, capable of delivering medication at local sites, have proved to be effective alternatives to administer the drug intravenously. Several product developments in stent graft balloon catheters are being approved by regulatory bodies for treating vascular diseases. For example – the FDA has recently approved an expandable balloon stent graft developed by W.L. Gore & Associates for treatment of the peripheral artery disease. Sophisticated healthcare infrastructure, rising awareness about angioplasty procedures, and technological advancements in stent graft balloon catheters across developed economies are further expected to influence growth of the market in the upcoming years.

    Browse Market Report with TOC Here - https://www.factmr.com/report/149/stent-graft-balloon-catheter-market

    Europe is estimated to be the most attractive market for stent graft balloon catheter. Asia-Pacific excluding Japan (APEJ) is expected to exhibit the highest CAGR in the global market through 2022. By indication, coronary artery disease will continue to account for a comparatively larger revenue share of the market than peripheral vascular disease.

    Based on end-users, hospitals will retain their dominance in the global stent graft balloon catheter market during 2017 to 2022. However, sales of stent graft balloon catheter in cardiac catheterization laboratories will continue to exhibit the fastest expansion at 5.1% CAGR through 2022.

    In terms of revenues, polyurethane, and nylon are expected to collectively account for over US$ 1,000 Mn revenues by 2022-end, based on raw materials. However, sales of polyurethane will continue to exhibit a comparatively faster expansion than sales of nylon through 2022.

    Competition Tracking

    Market players listed in Fact.MR’s report on the global market for stent graft balloon catheter include Medtronic Plc, Cordis Corporation, B. Braun Melsungen AG, Cook Medical INC, Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, Jotech GmbH, Cardionovum GmbH, Hexacath, Abbott Laboratories, and Meril Life Sciences Pvt. Ltd.

    Buy Hassle Free Global Market Research Report Here - https://www.factmr.com/checkout/149/S

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

older | 1 | .... | 1106 | 1107 | (Page 1108) | 1109 | 1110 | .... | 1146 | newer